Public list: Pharma Startups (4733) Cancer Therapeutics (1136)
Incanthera is an oncology company with a unique pipeline of technologies that target tumors. The lead cancer therapeutic opportunity is a new chemical entity called ICT2588, which has been designed to attack all forms of solid tumors while leaving he...Show all
Company (Alive / Active)
Phone: 0151 331 5100
Suite 315, Liverpool Science Park
IC2 146 Brownlow Hill
Liverpool, L3 5RF
United Kingdom
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Compounds containing a vascular disrupting agent | May 06, 2016 | May 01, 2018 | Patent |
| Methods of treating cancer using compounds containing a vascular disrupting agent | Oct 19, 2016 | Apr 10, 2018 | Patent |
| Compounds containing a vascular disrupting agent | Dec 17, 2013 | Jun 07, 2016 | Patent |
| Compounds | Oct 20, 2009 | Jan 06, 2015 | Patent |
| Compounds containing a vascular disrupting agent | Mar 27, 2008 | Apr 08, 2014 | Patent |
Download PDF